首页> 外文期刊>Current anaesthesia and critical care >Orthotopic liver transplantation in Jehovah's Witnesses
【24h】

Orthotopic liver transplantation in Jehovah's Witnesses

机译:耶和华见证人的原位肝移植

获取原文
获取原文并翻译 | 示例
       

摘要

Orthotopic liver transplantation (OLT) carries significant bleeding risks and has a high dependency on blood and blood-product transfusion. Jehovah's Witnesses conscientiously refuse transfusion of some or all blood products. OLT can be successful without the transfusion of allogeneic blood products. OLTs without blood or blood-product transfusion reduce not only the risks of transfusion reactions and transmission of blood-borne pathogens, but also complications of immunosup-pression and the likelihood of surgical re-intervention. This article explains the beliefs of Jehovah's Witnesses and clearly outlines the products they do and do not accept. An evidence-based protocol is described to meet the needs of these patients, highlighting the importance of multidisciplinary planning in advance. Pre-operative aims of blood augmentation can be achieved using erythropoietin, folic acid and iron supplementation. Intra-operative aims of blood-loss minimization are met surgically by: minimizing operation time; adopting the piggyback method; and using an argon beam coagulator, collagen and cellulose pads, and fibrin glues and sealants. During anaesthesia, patients should be kept hypotensive, normothermic and with low central venous pressure. Phlebotomy or acute normovolaemic haemodilution, intra-operative cell salvage and antifibrinolytics are also discussed. Patients should be monitored closely in the post-operative period. This protocol would be beneficial for all surgical patients and would reduce global blood use.
机译:原位肝移植(OLT)具有明显的出血风险,并且对血液和血液制品的输注高度依赖。耶和华见证人认真拒绝输血部分或全部血液。 OLT可以成功地输血同种异体血液产品。没有血液或血液制品输注的OLTs不仅降低了输血反应和血源性病原体传播的风险,而且还降低了免疫抑制并发症的发生率和再次进行手术干预的可能性。本文解释了耶和华见证人的信仰,并明确概述了他们接受和不接受的产品。描述了一种基于证据的方案来满足这些患者的需求,突出了事先进行多学科计划的重要性。使用促红细胞生成素,叶酸和铁补充剂可以达到术前补血的目的。手术中达到失血量最小化的目的可通过以下方式达到:采用the带法;并使用氩束凝结剂,胶原蛋白和纤维素垫以及纤维蛋白胶和密封剂。麻醉期间,患者应保持低血压,正常体温和低中心静脉压。还讨论了放血或急性降血红细胞血液稀释,术中细胞抢救和抗纤溶蛋白治疗。术后应密切监测患者。该方案对所有外科手术患者都是有益的,并且将减少整体血液使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号